225 Clinical Trials for: SEARCH[STUDY] MK-3475, Page 1 of 12

Hide Studies Not Seeking New Volunteers


A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK-3475 in Combination With INCB024360 in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Condition(s): Malignant Solid Tumour; Lymphoma, Large B-Cell, Diffuse; Carcinoma, Non-Small-Cell Lung; Transitional Cell Carcinoma of Digestive Tract; HER-2 Positive Breast Cancer; Carcinoma, Squamous Cell of Head and Neck; Ovarian Neoplasms; Adenocarcinoma of the Endometrium; Renal Cell Carcinoma Last Updated: August 24, 2015Recruiting